These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27162318)

  • 1. The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma.
    Suzuki H; Hanai N; Nishikawa D; Fukuda Y; Koide Y; Kodaira T; Tachibana H; Tomita N; Makita C; Hasegawa Y
    Jpn J Clin Oncol; 2016 Jul; 46(7):646-51. PubMed ID: 27162318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
    Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
    Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of comorbidity and anemia on outcome in patients with sinonasal carcinoma.
    Becker C; Dahlem KKK; Lange K; Ketterer MC; Pfeiffer J
    J Craniomaxillofac Surg; 2018 Aug; 46(8):1373-1378. PubMed ID: 29807754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma.
    Kılıç S; Kılıç SS; Kim ES; Baredes S; Mahmoud O; Gray ST; Eloy JA
    Int Forum Allergy Rhinol; 2017 Oct; 7(10):980-989. PubMed ID: 28859244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
    Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
    J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
    Singh B; Bhaya M; Zimbler M; Stern J; Roland JT; Rosenfeld RM; Har-El G; Lucente FE
    Head Neck; 1998 Jan; 20(1):1-7. PubMed ID: 9464945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma.
    Gimeno-Hernández J; Iglesias-Moreno MC; Gómez-Serrano M; Carricondo F; Gil-Loyzaga P; Poch-Broto J
    Acta Otolaryngol; 2011 Aug; 131(8):840-6. PubMed ID: 21492070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinoma.
    Nesic VS; Petrovic ZM; Sipetic SB; Jesic SD; Soldatovic IA; Kastratovic DA
    J Laryngol Otol; 2012 May; 126(5):516-24. PubMed ID: 22449728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring comorbidity in patients with head and neck cancer.
    Hall SF; Rochon PA; Streiner DL; Paszat LF; Groome PA; Rohland SL
    Laryngoscope; 2002 Nov; 112(11):1988-96. PubMed ID: 12439168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do geographic differences or socioeconomic disparities affect survival in sinonasal squamous cell carcinoma?
    Zhou AH; Chung SY; Patel VR; Unsal AA; Hsueh WD; Baredes S; Eloy JA
    Int Forum Allergy Rhinol; 2017 Dec; 7(12):1195-1200. PubMed ID: 29068562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
    Yasumatsu R; Nakashima T; Sato M; Nakano T; Kogo R; Hashimoto K; Sawatsubashi M; Nakagawa T
    Auris Nasus Larynx; 2017 Feb; 44(1):98-103. PubMed ID: 27108101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 18. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
    Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
    Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.